In a world that's moving faster day by day, these people from around the world spread the same positive message to love ...

Cosmetic surgeons are reporting a growing number of patients with sagging skin and facial hollowing after losing weight with ...

Biotechs investigate mitochondria-targeting drugs to claim a share in the weight loss drug market dominated by GLP-1RAs.

The persistent threat of reciprocal tariffs from US President Donald Trump has resulted in many trade deals, while the IMF ...

New research reveals GLP-1 drugs like Ozempic may reduce stroke risk and improve recovery. At the 22nd Annual Meeting of the (SNIS), three new studies were presented that explored whether GLP-1 inhibi ...

Explore the U.S. new F-47 fighter jet and its potential impact on global military balance, including reactions from Russia ...

ASX companies such as LTR Pharma are finding smarter ways to stretch the value of existing assets and launch into broader ...

Detailed price information for Novo Nordisk A/S ADR (NVO-N) from The Globe and Mail including charting and trades.

Novo Nordisk today announced sales and operating profit growth at constant exchange rates (CER) for the first six months of ...

Seeking Alpha's roundup of statements, announcements and remarks that could impact markets, sectors or individual stocks.

Bagsværd, Denmark, 29 July 2025 - Novo Nordisk today announced sales and operating profit growth at constant exchange rates (CER) for the first six months of 2025 and updated full-year sales and opera ...